Granite Point Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-200,000
Closed -$128K 200
2021
Q2
$128K Hold
200,000
﹤0.01% 154
2021
Q1
$188K Hold
200,000
0.01% 174
2020
Q4
$198K Hold
200,000
0.01% 147
2020
Q3
$144K Hold
200,000
0.01% 161
2020
Q2
$138K Buy
+200,000
New +$136K 0.01% 139

Granite Point Capital Management's CHAQ.WS Position: Q3 2021 in Review

Granite Point Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 200,000 shares — an estimated $128K sold.

Granite Point Capital Management first reported a position in CHAQ.WS in Q2 2020 and held it in 5 quarters. The position peaked at $198K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Granite Point Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Granite Point Capital Management sold 200,000 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $128K.
  • Granite Point Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q2 2020 and held it in 5 quarters.
  • Granite Point Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $198K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Granite Point Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.